Micronized Purified Flavonoid Fraction (MPFF) for Patients Suffering from Chronic Venous Disease: A Review of New Evidence
Open Access
- 13 February 2019
- journal article
- review article
- Published by Springer Nature in Advances in Therapy
- Vol. 36 (S1) , 20-25
Abstract
Chronic venous disease (CVD) is both prevalent and unavoidable in many people as a result of persistent or unalterable risk factors, the most important of which are advanced age, excess body weight, and family history. Given this inevitability, medical treatment is required to alleviate symptoms and slow disease progression. Venoactive drug therapy is emerging as a valuable treatment option for many CVD patients and micronized purified flavonoid fraction (MPFF) is the most widely prescribed and well-studied venoactive drug available. Recent evidence from animal models of venous hypertension and from clinical trials, as well as from systematic reviews, shows that MPFF is effective at alleviating many of the most common symptoms of CVD including leg pain, leg heaviness, sensations of swelling, cramps, and functional discomfort. In addition, MPFF improves the clinical signs of redness, skin changes, and edema, and improves quality of life. Collectively, these findings support the strong recommendation for MPFF treatment found in the 2018 international guidelines for the management of CVD. Funding: Servier.Keywords
This publication has 14 references indexed in Scilit:
- The Role of Endothelial Dysfunction and Inflammation in Chronic Venous DiseaseAnnals of Vascular Surgery, 2018
- Clinical efficacy and safety of a new 1000-mg suspension versus twice-daily 500-mg tablets of MPFF in patients with symptomatic chronic venous disorders: a randomized controlled trialInternational Angiology, 2017
- Predicted burden of venous diseasePhlebology: The Journal of Venous Disease, 2016
- Clinical acceptability study of once-daily versus twice-daily micronized purified flavonoid fraction in patients with symptomatic chronic venous disease: a randomized controlled trial.2015
- Progression in venous pathologyPhlebology: The Journal of Venous Disease, 2015
- Cellular and molecular basis of Venous insufficiencyVascular Cell, 2014
- Incidence and Risk Factors for Venous Reflux in the General Population: Edinburgh Vein StudyEuropean Journal of Vascular and Endovascular Surgery, 2014
- Chronic Venous DiseaseNew England Journal of Medicine, 2006
- The Influence of Environmental Factors in Chronic Venous InsufficiencyAngiology, 2003
- Prevalence and Risk Factors of Chronic Venous InsufficiencyAngiology, 2001